Comparison between Bafna Pharmaceuticals IPO and First Winner Industries IPO.
Bafna Pharmaceuticals IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while First Winner Industries IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Bafna Pharmaceuticals IPO is up to ₹25.60 Cr whereas the issue size of the First Winner Industries IPO is up to ₹68.75 Cr. The final issue price of Bafna Pharmaceuticals IPO is ₹40.00 per share and of First Winner Industries IPO is ₹125.00 per share.
| Bafna Pharmaceuticals IPO | First Winner Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹115.00 per share | |
| Issue Price (Upper) | ₹125.00 per share | |
| Issue Price (Final) | ₹40.00 per share | ₹125.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 50 shares | |
| Fresh Issue Size | 64,00,206 shares | 55,00,043 shares |
| Fresh Issue Size (Amount) | up to ₹25.60 Cr | up to ₹68.75 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 64,00,206 shares | 55,00,043 shares |
| Issue Size Total (Amount) | up to ₹25.60 Cr | up to ₹68.75 Cr |
Bafna Pharmaceuticals IPO opens on May 27, 2008, while First Winner Industries IPO opens on Jun 09, 2008. The closing date of Bafna Pharmaceuticals IPO and First Winner Industries IPO is May 30, 2008, and Jun 17, 2008, respectively.
| Bafna Pharmaceuticals IPO | First Winner Industries IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 27, 2008 | Jun 09, 2008 |
| Issue Close | May 30, 2008 | Jun 17, 2008 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Jun 27, 2008 | Jul 08, 2008 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bafna Pharmaceuticals IPO P/E ratio is , as compared to First Winner Industries IPO P/E ratio of .
| Bafna Pharmaceuticals IPO | First Winner Industries IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 71.07 | 59.96 | ||||
| Promoter Shareholding (Post-Issue) | 42.6 | 41.36 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹63.92 Cr. | ₹221.66 Cr. | ||||
| ROE | ||||||
| ROCE | 18.95 | |||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 10.65 | 13.36 |
In the Bafna Pharmaceuticals IPO Retail Individual Investors (RII) are offered 32,00,000 shares while in First Winner Industries IPO retail investors are offered 32,00,000 shares. Qualified Institutional Buyers (QIB) are offered in Bafna Pharmaceuticals IPO and 27,00,000 shares in First Winner Industries IPO.
| Bafna Pharmaceuticals IPO | First Winner Industries IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 27,00,000 shares | |
| NII | 32,00,000 shares | 8,10,000 shares |
| RII | 32,00,000 shares | 18,90,000 shares |
| Employee | 1,00,000 shares | |
| Others | ||
| Total | 64,00,000 shares | 55,00,000 shares |
Bafna Pharmaceuticals IPO subscribed 4.88x in total, whereas First Winner Industries IPO subscribed 1.26x.
| Bafna Pharmaceuticals IPO | First Winner Industries IPO | |
|---|---|---|
| QIB (times) | 1.05x | |
| NII (times) | 1.57x | 1.84x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 8.20x | 1.32x |
| Employee (times) | 1.08x | |
| Other (times) | ||
| Total (times) | 4.88x | 1.26x |
